Oxaliplatin in Combination with Leucovorin and 5-Fluorouracil for Advanced Gastric Cancer
Peng An
Abstract
Peng An
Abstract
Objective To evaluate the effects and adverse reactions of oxaliplatin(OXA) in combination with leucovorin (CF)and 5-fluorouracil(5-Fu) regimen for patients with advanced gastric cancer. Methods OXA 130mg/m 2 iv 3h d1,CF 200 mg iv 2h followed by 5-Fu 500mg iv plus 5-Fu 2.4 g/m 2 continuous infusion 46 hours, repeated every 3 weeks. Tumor assessment was done after 3 cycles and the effective cases were confirmed after 4 weeks. Results Among 46 patients with advanced gastric cancer, 3 patients reached complete response(CR), 20 partial response (PR).The overall response rate (CR+PR) was 50%. The median progression free survival was 5.7 months.The median survival of all patients was 10.5 months. The major adverse effect was mild neuro-sensory toxicity, nausea/vomiting and myelosuppression. Conclusion Oxaliplatin in Combination with leucovorin and 5-fluorouracil shows good efficacy in treatment advanced gastric cancer.The toxicity is mild and tolerate.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the effects and adverse reactions of oxaliplatin(OXA) in combination with leucovorin (CF)and 5-fluorouracil(5-Fu) regimen for patients with advanced gastric cancer. Methods OXA 130mg/m 2 iv 3h d1,CF 200 mg iv 2h followed by 5-Fu 500mg iv plus 5-Fu 2.4 g/m 2 continuous infusion 46 hours, repeated every 3 weeks. Tumor assessment was done after 3 cycles and the effective cases were confirmed after 4 weeks. Results Among 46 patients with advanced gastric cancer, 3 patients reached complete response(CR), 20 partial response (PR).The overall response rate (CR+PR) was 50%. The median progression free survival was 5.7 months.The median survival of all patients was 10.5 months. The major adverse effect was mild neuro-sensory toxicity, nausea/vomiting and myelosuppression. Conclusion Oxaliplatin in Combination with leucovorin and 5-fluorouracil shows good efficacy in treatment advanced gastric cancer.The toxicity is mild and tolerate.
Key concepts: Oxaliplatin, Medicine, Fluorouracil, Vomiting, Nausea, Regimen, Gastroenterology, Internal medicine